Page last updated: 2024-08-23

zidovudine and Growth Disorders

zidovudine has been researched along with Growth Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Aizire, J; Atuhaire, P; Boivin, MJ; Familiar, I; Fowler, MG; Katumbi, C; Maliwichi, L; Mutebe, A; Ogwang, LW; Sikorskii, A; Taha, T1
De Bruyn, G; Gray, GE; Harwell, JI; Lurie, MN; McGarvey, ST; Triche, EW; Venkatesh, KK1
Dabis, F; Elenga, N; Fassinou, P; Msellati, P; Viho, I1
Bryson, YJ; Geffner, ME; Israele, V; Landaw, EM; Scott, ML; Stiehm, ER; Yeh, DY1
Caballero, B; Henderson, RA; Hutton, N; Talusan, K; Yolken, RH1

Trials

1 trial(s) available for zidovudine and Growth Disorders

ArticleYear
Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
    Tropical medicine & international health : TM & IH, 2010, Volume: 15, Issue:11

    Topics: Adult; Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Growth Disorders; HIV Infections; Humans; Infant Formula; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Age; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Young Adult; Zidovudine

2010

Other Studies

4 other study(ies) available for zidovudine and Growth Disorders

ArticleYear
Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age.
    AIDS (London, England), 2022, 03-15, Volume: 36, Issue:4

    Topics: Child; Female; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Longitudinal Studies; Malawi; Uganda; Zidovudine

2022
[Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].
    Bulletin de la Societe de pathologie exotique (1990), 2004, Volume: 97, Issue:4

    Topics: Adult; Anemia, Hypochromic; Anti-HIV Agents; Cohort Studies; Comorbidity; Cote d'Ivoire; Epilepsy, Generalized; Failure to Thrive; Female; Fetus; Growth Disorders; HIV Infections; Humans; Infant; Male; Mitochondria; Muscle Hypotonia; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Protein-Energy Malnutrition; Psychomotor Disorders; Randomized Controlled Trials as Topic; Zidovudine

2004
In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children.
    Pediatric research, 1993, Volume: 34, Issue:1

    Topics: Child; Child, Preschool; Erythropoiesis; Female; Growth Disorders; Growth Hormone; HIV Infections; HIV-1; Humans; In Vitro Techniques; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Male; Zidovudine

1993
Resting energy expenditure and body composition in children with HIV infection.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Oct-01, Volume: 19, Issue:2

    Topics: Adipose Tissue; Anthropometry; Anti-HIV Agents; Arm; Body Composition; Body Water; Child; Child Development; Child, Preschool; Didanosine; Energy Intake; Energy Metabolism; Female; Growth Disorders; HIV Infections; Humans; Male; Muscle Development; Muscle, Skeletal; Skinfold Thickness; Zidovudine

1998